HomeGENB • NASDAQ
add
Generate Biomedicines Inc
Previous close
$12.65
Day range
$12.01 - $13.95
Year range
$11.44 - $15.32
Avg Volume
207.30K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | 2025info | Y/Y change |
|---|---|---|
Revenue | 31.89M | 55.89% |
Operating expense | 42.26M | 0.41% |
Net income | -203.15M | -16.91% |
Net profit margin | -636.99 | 25.00% |
Earnings per share | — | — |
EBITDA | -221.89M | -22.19% |
Effective tax rate | -0.07% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 221.50M | -43.73% |
Total assets | 330.18M | -36.29% |
Total liabilities | 140.35M | -13.58% |
Total equity | 189.83M | — |
Shares outstanding | 50.30M | — |
Price to book | -1.03 | — |
Return on assets | -34.63% | — |
Return on capital | -42.51% | — |
Cash Flow
Net change in cash
| (USD) | 2025info | Y/Y change |
|---|---|---|
Net income | -203.15M | -16.91% |
Cash from operations | -200.62M | -70.38% |
Cash from investing | 116.77M | 302.28% |
Cash from financing | 28.06M | -69.28% |
Net change in cash | -55.79M | 33.70% |
Free cash flow | -119.10M | — |
About
Generate:Biomedicines is a biotechnology company founded in 2018 and headquartered in Somerville, Massachusetts. It specializes in using machine learning to design and optimize proteins for therapeutic applications, with a focus on immunology, oncology, and infectious diseases. Wikipedia
Founded
2018
Headquarters
Website
Employees
312
